Boothbay Fund Management’s NeuroSense Therapeutics NRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-12,170
Closed -$48K 2201
2022
Q1
$48K Buy
+12,170
New +$48K ﹤0.01% 1803